Pharma readings

By Miguel Tovar | Miguel Tovar created a magazine on Flipboard. “Pharma readings on Flipboard” is available with thousands of other magazines and all the news you care about. Download Flipboard for free and search for “Miguel Tovar”.

21st Century

Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month

Pfizer and Merck KGaA’s cancer immunotherapy won approval from U.S. regulators for patients with a rare form of skin cancer, and the companies plan …

Eli Lilly CEO Ricks Says AHCA Won't Hurt Drug Prices

David Ricks, president and chief executive officer at Eli Lilly, and Indiana Governor Eric Holcomb discuss how changes to U.S. health coverage under …

FDA approves Pfizer, German Merck immunotherapy for skin cancer

(Reuters) - U.S. health regulators on Thursday approved a drug developed by Merck KGaA and Pfizer Inc that helps the immune system to fight a rare form of skin cancer once it has spread to other parts of the body.<p>The Food and Drug Administration said it approved Bavencio, known chemically as …

Cancer

Not All Cardiologists Trust Amgen's Cholesterol Drug Study

The most eagerly awaited study presented at last week’s American College of Cardiology meeting was Amgen’s FOURIER clinical trial. This study involved 27,564 patients with cardiovascular (CV) disease, 80% of whom had already experienced a heart attack. The goal was to show that Amgen’s drug, the …

Clinical Trials

Eli Lilly Wants You to Know Its Price Hikes Don't Work - Bloomberg Gadfly

The drug-pricing debate focuses too much on President Donald Trump's Twitter account, and too little on the fact that price hikes don't work that …

Health Care

Trumpcare may be healthy for Big Pharma and insurers

<b>New York (CNN) —</b> Obamacare may eventually become Trumpcare. And even though there are issues that must be worked out before the Affordable Care Act is repealed and replaced by the American Health Care Act, investors are excited. Health care stocks are soaring.<p>Two big health care ETFs -- the Health …

Health Care

Esperion Therapeutics Sees Clear FDA Path For Its Heart Drug

Esperion Therapeutics, a small biotech company that is trying to develop a new cholesterol drug, has a salve for its investors this morning: it says the Food and Drug Administration has agreed that the company’s medicine, bempadoic acid, could be approved based on blood test results, before a …

Investing

AstraZeneca diabetes drug cuts death rates in real world trial

AstraZeneca’s Farxiga diabetes drug sharply reduced the chance of both hospitalisation and death for sufferers from the type 2 variety of the disease …

Diabetes

New GlaxoSmithKline chief to earn 25% less than her predecessor

GSK says Emma Walmsley’s potential £8.8m a year pay deal is lower due to lesser experience<p>GlaxoSmithKline’s new chief executive, Emma Walmsley, will be paid 25% less than her predecessor, Sir Andrew Witty.<p>Britain’s biggest pharmaceutical company said her potential £8.8m a year pay deal was lower …

Budgeting
Pfizer
Genetics

FDA, EMA Accept Filings from Merck and Pfizer for Type 2 Diabetes Medications

NewsThe Prescription Drug User Fee Act (PDUFA) action date from the FDA is in December 2017 for the three NDAs.Topics: Biotech

Diabetes

Novartis wins FDA approval for breast cancer drug aiming for Pfizer's Ibrance

Novartis on Monday won U.S. Food and Drug Administration approval for Kisqali to treat postmenopausal women with a difficult-to-treat form of breast cancer, challenging Pfizer's fast-growing Ibrance.<p>The approval for Kisqali, previously known as LEE011 and to be administered in combination with …

Cancer

Sanofi hails broader promise of eczema medicine

Sanofi has hailed an eczema medicine tipped to be the biggest drug launch of the year as an “inflection point” as it tries to plug a revenue gap left …

Data on heart benefits of Amgen drug is key to unlocking sales

(Reuters) - Data that should help unlock the sales potential of a potent new cholesterol medicine will be unveiled at the American College of Cardiology meeting this week as the future of the only rival drug rests with the courts in an ongoing patent dispute.<p>Highly anticipated results from a …

Health Care
Public Health

Will "Biosimilar" Medications Reduce the Cost of Biologic Drugs?

Not necessarily

Investing

Eli Lilly CEO: We’d Like to See a Health Care System That Rewards Innovation

Eli Lilly (LLY) CEO David Ricks appeared exclusively on the FOX Business Network Wednesday to share his thoughts on congressional Republicans’ plan to repeal and replace the Affordable Care Act.<p>“We applaud Speaker Ryan and Secretary Price for getting out and putting a proposal on the table that …

Health Care

Sanofi gears up for European generic drugs unit sale: sources

| LONDON/FRANKFURT<p>French drug maker Sanofi (SASY.PA) is looking to hire advisers for the sale of its European generic drug business by the end of the month, sources told Reuters, ahead of an auction process which is set to start after the summer.<p>A handful of banks have been shortlisted to present …

21st Century

Sanofi Launches Digital Clinical Trials to Improve Recruitment, Reduce Trial Times

NewsWithout clinical trials, new medicine may never make it from the research lab to patients in need.Topics: Clinical Trials

Clinical Trials

Sanofi is gearing up to sell its generic drugs unit in Europe

LONDON/FRANKFURT, March 8 (Reuters) - French drug maker Sanofi is looking to hire advisers for the sale of its European generic drug business by the end of the month, sources told Reuters, ahead of an auction process which is set to start after the summer.<p>A handful of banks have been shortlisted to …

Banking

Trump isn't a 'worst case scenario' for biotech, analyst says

Biotech stocks won't be hit with a "worst case scenario," analyst Michael Yee told CNBC, referring to President Donald Trump's latest attack on the …

UK court delivers high-stakes decision on world's best-selling drug

South Korea's Samsung Bioepis has won a high-stakes court case on Friday against U.S. drug firm AbbVie for a biosimilar of the world's best-selling …

Investing

Japan Joins Trump in Drug Price War Crimping Big Pharma Profits - Bloomberg

President Donald Trump has pledged to reverse what he describes as "astronomical" drug prices in the U.S. Thousands of miles away, Japan, long a …

Investing

Roche's New Drugs May Protect its Old Ones - Bloomberg Gadfly

Roche Holding AG's blockbuster cancer drugs face a huge impending sales decline in the next few years. Its investors aren't worried.<p>The company's …

Investing

Big Pharma Is Losing a Fortune Trying to Cure Alzheimer's - Bloomberg

Alzheimer’s disease is upending the rules of drug discovery, with a handful of companies abandoning caution to keep pursuing an elusive hypothesis …

Novartis cancer division races to catch up with rivals

ZURICH (Reuters) - Novartis is making progress in its bid to catch rivals developing drugs that harness the immune system to fight cancer, one of its top research scientists and latest recruit from Harvard University told Reuters in an interview.<p>Peter Hammerman joined the Swiss firm in late 2016, …

Cancer

Orphan drugs attract rich returns for pharmaceuticals

Scientific advances and legal incentives have encouraged investment

Health Care